Prognostic value of UPA, PAI-1, and PAI-2 mRNA expression in primary breast cancer.

被引：0
|
作者：
Spyratos, F
Bouchet, C
Tozlu, S
Labroquère, M
Vignaud, S
Becette, V
Lidereau, R
Bièche, I
机构：
[1] Ctr Rene Huguenin, St Cloud, France
[2] Fac Sci Pharmaceut & Biol Paris, Genet Mol Lab, Paris, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
323
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [41] Quantitative protein network monitoring for uPA and PAI-1 in breast cancer
    Malinowsky, K.
    Boellner, C.
    Berg, D.
    Walch, A.
    Schuster, T.
    Schmitt, M.
    Becker, K. -F.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 172 - 172
  • [42] PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells
    Alvarez-Millán, JJ
    Bocos, C
    Ferrín, V
    Lucas, AR
    Ruibal, A
    Schneider, J
    ONCOLOGY, 2002, 62 (03) : 286 - 290
  • [43] Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptides
    Muehlenweg, B
    Guthaus, E
    de Prada, NA
    Schmitt, M
    Schmiedeberg, N
    Kotzsch, M
    Creutzburg, S
    Kramer, MD
    Kessler, H
    Wilhelm, OG
    Magdolen, V
    THROMBOSIS RESEARCH, 2000, 98 (01) : 73 - 81
  • [44] PAI-1 and PAI-2 interact with different subunits of proteasome in endothelial cells
    Boncela, J. M.
    Przygodzka, P.
    Wyroba, E.
    Cierniewski, C. S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 : 54 - 54
  • [45] PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN PREECLAMPSIA - DECREASES IN PAI-2 SUGGESTING PLACENTAL OR FETAL COMPLICATIONS AND FETUS ASSUMED TO BE ONE OF REGULATORS OF PAI-2 SYNTHESIS
    HE, S
    BREMME, K
    ALMQVIST, I
    BLOMBACK, M
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1302 - 1302
  • [46] Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma
    Chautard, D
    Dalifard, I
    Chassevent, A
    Guyetant, S
    Daver, A
    Vielle, B
    Soret, JY
    UROLOGY, 2004, 63 (06) : 1055 - 1060
  • [47] Micromethod for determination of uPA and PAI-1 from preoperative core-needle biopsies in breast cancer.
    Abraha, RS
    Thomssen, C
    Harbeck, N
    Mueller, V
    Baack, K
    Schmitt, M
    Jaenicke, F
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S144 - S144
  • [48] Prognostic importance of plasminogen inhibitor-1 (PAI-1) in primary breast cancer
    Fersis, N
    Kauffmann, M
    Kramer, MD
    Wittmann, G
    Wallwiener, D
    Bastert, G
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1996, 56 (01) : 28 - 34
  • [49] Feasibility of Measuring the Prognostic Factors uPA and PAI-1 in Core Needle Biopsy Breast Cancer Specimens
    Thomssen, Christoph
    Harbeck, Nadia
    Dittmer, Juergen
    Abraha-Spaeth, Shanti R.
    Papendick, Nancy
    Paradiso, Angelo
    Lisboa, Bjoern
    Jaenicke, Fritz
    Schmitt, Manfred
    Vetter, Martina
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (14) : 1028 - 1029
  • [50] K167 expression and uPA/PAI-1 level: adjuvant chemotherapy markers in intermediate risk early breast cancer.
    Deluche, Elise
    Venat-Bouvet, Laurence
    Leobon, Sophie
    Fermeaux, Veronique
    Aubard, Yves
    Saidi, Nadira
    Jammet, Isabelle
    Tubiana-Mathieu, Nicole
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345